Summarizing our data, we suggest that assessing IL-18BP, IP-10, and/or IL-8 may assist in identifying latent disease activity in transplanted FHL patients whose clinical condition and laboratory status is still normal. The gene discussed is IL18BP; the disease is hemophagocytic syndrome.